Enanta Pharmaceuticals reported $8.48M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Amgen AMGN:US $ 1.38B 130M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arrowhead Research ARWR:US $ 17.86M 1.67M
AstraZeneca AZN:LN 2.57B 76M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Clovis Oncology CLVS:US $ 32.92M 2.98M
Enanta Pharmaceuticals ENTA:US $ 8.48M 151K
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Insmed INSM:US $ 57.18M 5.63M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Marinus Pharmaceuticals MRNS:US 6.83M 3.55M
Merk MRK:US $ 2.25B 376M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Novavax NVAX:US $ 73.16M 9.97M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Vital Therapies VTL:US $ 3.43M 17.44M
YTE INCY:US $ 168.86M 15.06M